Metabolic fate of ultratrace levels of GeCl4 in the rat and in vitro studies on its basal cytotoxicity and carcinogenic potential in Balb/3T3 and HaCaT cell lines

被引:16
作者
Sabbioni, E. [2 ]
Fortaner, S. [1 ]
Bosisio, S.
Farina, M. [1 ]
Del Torchio, R. [1 ]
Edel, J. [3 ]
Fischbach, M. [3 ]
机构
[1] Joint Res Ctr, European Commiss, ECVAM Unit, Inst Hlth & Consumer Protect, I-21027 Ispra, Varese, Italy
[2] Univ G dAnnunzio, CeSI, Ageing Res Ctr, I-66100 Chieti, Italy
[3] ABICH Srl, I-28924 Verbania Fondotoce, VB, Italy
关键词
germanium; metabolic patterns; cytotoxicity; carcinogenic potential; rats; Balb/3T3; HaCaT; GERMANIUM DIOXIDE; ANTITUMOR-ACTIVITY; NEPHROTOXICITY; TRANSFORMATION; NANOPARTICLES; MUTAGENICITY; MACROPHAGES; RETENTION; TISSUES;
D O I
10.1002/jat.1469
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The use of germanium (Ge) and the possibility of exposure to trace and ultratrace amounts of this element is increasing. Germanium is widely used in the industrial field as a semiconductor and also as a dietary supplement, an elixir to 'promote health and cure disease'(e.g. cancer and AIDS). More recently, germanium nanoparticles, ranging in size from 60 to 80 nm, have been developed as a potential spleen imaging agent. Like other metal-based nanoparticles used in nanomedicine, Ge nanoparticles may release trace and ultratrace amounts of Ge ions when injected. The metabolic fate and toxicity of these ions still needs to be evaluated. In this study the metabolic fate of a cationic tetravalent Ge species was studied in vivo by injecting rats i.p. with ultratrace amounts of Ge (80 ng kg(-1)) as [Ge-68]GeCl4. The cytotoxicity and carcinogenic potential was assessed in vitro using immortallised human skin keratinocytes and mouse fibroblasts (HaCaT and Balb/c 3T3 cell lines, respectively). At 24 h post-exposure Ge was poorly retained in rat tissues (kidney, liver, intestine, femur, spleen and the heart were the organs with the highest Ge concentration). In the blood, Ge was rapidly cleared, being almost equally distributed between plasma and red blood cells. The excretion was mainly via the urine. The hepatic and renal intracellular distribution showed the highest recovery of Ge in the cytosol and the nuclear fractions. Chromatographic separation and ultrafiltration experiments on kidney and liver cytosols showed that the bulk of Ge was associated with low molecular weight components, representing a 'mobile pool' of the element in the body. However, a significant part of the element was able to interact with biological macromolecules which could be responsible for the presence of Ge in the liver and kidney after 7 days. The in vitro experiments confirmed the low degree of cytotoxicity of GeCl4 both in HaCaT and Balb/3T3. The latter model was more sensitive to the toxic effects induced by Ge as shown by a colony forming efficiency (CFE) greater than 70% at 700 mu M of exposure. At the highest exposure concentration tested (700 mu M) GeCl4 failed to induce morphological neoplastic transformation of the cells, suggesting for the first time that a cationic form of Ge ions has no carcinogenic potential. This supports the results of the only study reported in mice, treated orally long-term to an anionic species of Ge such as sodium germanate (Kanisawa and Schroeder, 1967). Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:34 / 41
页数:8
相关论文
共 38 条
[1]  
[Anonymous], 1995, GRAYS ANATOMY, V38th
[2]  
BERTOLERO F, 1987, P OCC ENV CHEM HAZ, P478
[3]  
Celis A, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P5
[4]   Thermal behavior and film formation from an organogermanium polymer/nanoparticle precursor [J].
Chiu, Hsiang Wei ;
Kauzlarich, Susan M. ;
Sutter, Eli .
LANGMUIR, 2006, 22 (12) :5455-5458
[5]   Germanium oxide inhibits the transition from G2 to M phase of CHO cells [J].
Chiu, SJ ;
Lee, MY ;
Chen, HW ;
Chou, WG ;
Lin, LY .
CHEMICO-BIOLOGICAL INTERACTIONS, 2002, 141 (03) :211-228
[6]   Cell transformation assays as predictors of human carcinogenicity -: The report and recommendations of ECVAM Workshop 39 [J].
Combes, R ;
Balls, M ;
Curren, R ;
Fischbach, M ;
Fusenig, N ;
Kirkland, D ;
Lasne, C ;
Landolph, J ;
LeBoeuf, R ;
Marquardt, H ;
McCormick, J ;
Müller, L ;
Rivedal, E ;
Sabbioni, E ;
Tanaka, N ;
Vasseur, P ;
Yamasaki, H .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 1999, 27 (05) :745-767
[7]  
DUDLEY HC, 1952, AMA ARCH IND HYG OCC, V6, P263
[8]  
Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO
[9]  
2-U
[10]   Mutagenicity, carcinogenicity and teratogenicity of germanium compounds [J].
Gerber, GB ;
Leonard, A .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 1997, 387 (03) :141-146